The US Food and Drug Administration (FDA) approved Exact Sciences' next-generation multitarget stool DNA (mt-sDNA) test, Cologuard Plus, for use in adults 45 or older who are at average risk for ...
BRISBANE, Calif., July 9, 2026 /PRNewswire/ -- Freenome, an early cancer detection company developing blood-based screening tests, today announced favorable results from its pivotal clinical ...
Only Abbott offers a complete screening solution combining end-to-end support with both stool- and blood-based colorectal cancer screening options, giving healthcare providers more ways to help ...
Multitarget stool-based tests are showing promise for colorectal cancer (CRC) screening in average-risk individuals and could edge out the current standard fecal immunochemical test (FIT). These new ...
Please provide your email address to receive an email when new articles are posted on . Newly available noninvasive colorectal cancer tests have opened the doors to an uptick in screening, especially ...
The test is designed for people aged 45 years and above who are at average colorectal cancer risk. Credit: aslysun / Shutterstock.com. · Medical Device Network · aslysun / Shutterstock.com. The US ...
– Significant performance improvement seen across all subtypes of advanced precancerous lesions, which are important to detect for potential colorectal cancer prevention – – Overall detection of ...
Blood-based screening for colorectal cancer (CRC) should only be used with patients who are not completing other endorsed screening options, according to a study. This study aimed to use a simulation ...
Colorectal cancer screening preferences differ across underserved populations, suggesting that aligning screening options with patient preferences may help improve screening uptake and adherence. A ...
With Cologuard Plus, an American Cancer Society (ACS)-preferred stool-based screening option, and SimpleScreen CRC, a blood-based option for eligible adults who decline or do not complete preferred ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results